Results 201 to 210 of about 7,267,888 (348)

Next‐generation proteomics improves lung cancer risk prediction

Molecular Oncology, EarlyView.
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj, Clara Frick, Ben Schöttker, Bernd Holleczek, Hermann Brenner   +4 more
wiley   +1 more source

Letter to the editor regarding to "effect of Tai Chi combined with visual-action-sensory rehabilitation therapies on cognitive function in acute ischemic stroke: a study protocol for a randomized controlled trial". [PDF]

Ann Med
Fu X, Huang S.
europepmc   +1 more source

Towards Verification of the Pastry Protocol Using TLA +

, 2011
Tianxiang Lu, Stephan Merz, Christoph Weidenbach   +2 more
openalex   +2 more sources

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

Molecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute, Júlia Huguet‐Pradell, Jordi Abril‐Fornaguera, Albert Gris‐Oliver, Alex Rialdi, Elisa Fernández‐Martínez, Carla Montironi, Vanessa Del Pozo, Peter Houghton, Laura Zanatto, Agavni Mesropian, Ieva Keraite, Swan Thung, Carolina Armengol, Pau Sancho‐Bru, Ernesto Guccione, Roser Pinyol, Josep M. Llovet   +17 more
wiley   +1 more source

The Prospective Registration of Clinical Trial Protocols: When Is a Health-Related Intervention Study Not a 'Clinical Trial'? [PDF]

Nurs Rep
Bressington D, Suriyawong W, Pipatpiboon N, Gray R.   +3 more
europepmc   +1 more source

Towards the co‐ordination of terrestrial ecosystem protocols across European research infrastructures [PDF]

, 2017
L. G. Firbank, Chiara Bertora, David Blankman, Gemini Delle Vedove, Mark Frenzel, Carlo Grignani, Elli Groner, Miklós Kertész, Eveline J. Krab, Gioṙgio Matteucci, Christina Menta, Carsten W. Mueller, Jutta Stadler, William E. Kunin   +13 more
openalex   +1 more source

An Enhanced Efficient Leach Protocol (EELP) with Novel Cross Layer Technique to forward the Data Packets in Wireless Sensor Networks

, 2021
N.C. Sachithanantham, V. Jaiganesh
openalex   +1 more source

Exploiting metabolic adaptations to overcome dabrafenib treatment resistance in melanoma cells

Molecular Oncology, EarlyView.
We show that dabrafenib‐resistant melanoma cells undergo mitochondrial remodeling, leading to elevated respiration and ROS production balanced by stronger antioxidant defenses. This altered redox state promotes survival despite mitochondrial damage but renders resistant cells highly vulnerable to ROS‐inducing compounds such as PEITC, highlighting redox
Silvia Eller, Susanne Ebner, Carmen Haselrieder, Julia K. Günther, Astrid Drasche, Sophie Strich, Chiara Volani, Andrea Medici, Aleksandar Nikolajevic, Alex Deltedesco, Johannes E. Sigmund, Michael J. Blumer, Martin Hermann, Johanna Vanacker, Gerald Brandacher, Eduard Stefan, Omar Torres‐Quesada, Jakob Troppmair   +17 more
wiley   +1 more source

Safety and efficacy of tirofiban in preventing neurological deterioration in acute ischemic stroke (TREND): Protocol for an investigator-initiated, multicenter, prospective, randomized, open-label, masked endpoint trial

Jing Wang, Sijie Li, Chuanhui Li, Chuanjie Wu, Haiqing Song, Qingfeng Ma, Xunming Ji, Wenbo Zhao, for the TREND Investigators   +8 more
openalex   +1 more source

Image Cytometry Protocols [PDF]

Journal of Histochemistry & Cytochemistry, 2013
van Noorden, Cornelis J. F., Chieco, Pasquale   +1 more
openaire   +2 more sources